Filing Details

Accession Number:
0002001011-24-000093
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-02 20:05:58
Reporting Period:
2024-11-27
Accepted Time:
2024-12-02 20:05:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216074 L John Lamattina 555 Heritage Drive
Suite 200
Jupiter FL 33458
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-27 2,406 $52.30 31,921 No 4 M Direct
Common Stock Disposition 2024-11-27 2,406 $123.65 29,515 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2024-11-27 2,406 $0.00 2,406 $52.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-04-24 No 4 M Direct
Footnotes
  1. This Option was previously reported as a Grant of 2,754 shares on April 24, 2015, which vested in full on April 24, 2016, at an exercise price of $89.7500 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.